Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Prospective, Randomized Trial To Demonstrate Improved Metabolic Control of PEN VS Dianeal Only in Diabetic CAPD and APD Patients - The Impendia Trial

NCT00567489 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT00567489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00567489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Prospective, Randomized Trial To Demonstrate Improved Metabolic Control of PEN VS Dianeal Only in Diabetic CAPD and APD Patients - The Impendia Trial
Lead sponsor
Vantive Health LLC
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
July 31, 2011
Enrollment
137 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

apd, capd, diabetes, esrd